Table 4 Number of women experiencing a drug related adverse events following infusion with ferric carboxymaltose (total number of women infused n = 65)
From: Intravenous ferric carboxymaltose for anaemia in pregnancy
Adverse event | n (%) |
|---|---|
Any adverse event | 13 (20) |
Local (injection site irritation) | |
Slight burning sensation | 5 (8) |
Systemic | |
Hypotension | 1 (1.5) |
Headache | 4 (6) |
Nausea/Vomiting | 1 (1.5) |
Pruritus | 2 (3) |